Competitors:
Tizona Therapeutics
Tizona TherapeuticsThemis Bioscience Company Culture
Themis Bioscience Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterThemis Bioscience Company Information
Themis Bioscience Company Overview
Developer of vaccines to prevent tropical infections. The company's core lead technology, Themaxyn, is a novel, patent-protected vaccine platform, that will be used to create novel vaccines for emerging tropical and travelers' diseases, including dengue, chikungunya and yellow fever virus.
Themis Bioscience was founded in 2009 and its current CEO is Erich Tauber. Since its inception 17 years ago, Themis Bioscience has grown to 11 employees.
| Headquarter | , Vienna 1190 Austria |
|---|---|
| Website | www.themisbio.com |
| Founding Date | 2009 |
| Company Status | Private |
Themis Bioscience Careers
Themis Bioscience Jobs
No Recent Jobs found for Themis Bioscience on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let Themis Bioscience Know You Want To Work There
Frequently Asked Questions regarding Themis Bioscience
What is Themis Bioscience address?
Themis Bioscience location is at , Vienna
How many employees work in Themis Bioscience?
Themis Bioscience has 11 employees
Who are Themis Bioscience competitors?
Themis Bioscience main competitors are Tizona Therapeutics
Who is Themis Bioscience leadership?
are part of Themis Bioscience leadership, Erich Tauber is the CEO
×